Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success

Atrial Fibrillation

Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review

Heart.

Chue CD, Kwok CS, Wong CW, Patwala A, Barker D, Zaidi A, Mamas MA, Cunnington C, Ahmed FZ

doi: 10.1136/heartjnl-2016-310852.

Heart, Artery and Coronary DiseasesHypertensionThrombosis and Stroke

Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support

Circ Heart Fail.

Kiernan MS, Grandin EW, Brinkley M Jr, Kapur NK, Pham DT, Ruthazer R, Rame JE, Atluri P, Birati EY, Oliveira GH, Pagani FD, Kirklin JK, Naftel D, Kormos RL, Teuteberg JJ, DeNofrio D

doi: 10.1161/

Cardiac Arrest or Death

Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry

Eur J Heart Fail.

Cikes M, Jakus N, Claggett B, Brugts JJ, Timmermans P, Pouleur AC, Rubis P, Van Craenenbroeck EM, Gaizauskas E, Grundmann S, Paolillo S, Barge-Caballero E, D'Amario D, Gkouziouta A, Planinc I, Veenis JF, Jacquet LM, Houard L, Holcman K, Gigase A, Rega F, Rucinskas K, Adamopoulos S, Agostoni P, Biocina B, Gasparovic H, Lund LH, Flammer AJ, Metra M, Milicic D, Ruschitzka F, PCHF-VAD registry.

doi: 10.1002/ejhf.1568.

Heart, Artery and Coronary DiseasesHeart Failure

Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar

Eur Heart J.

Gutman SJ, Costello BT, Papapostolou S, Voskoboinik A, Iles L, Ja J, Hare JL, Ellims A, Kistler PM, Marwick TH, Taylor AJ

doi: 10.1093/eurheartj/ehy437.

Cardiac Arrest or DeathAtrial FibrillationHeart, Artery and Coronary Diseases

Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study)

Circ Arrhythm Electrophysiol.

Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, Zarse M, Hohnloser SH, Kautzner J, Willems S; SMS Investigators

doi: 10.1161/CIRCEP.116.004422.

Heart FailureThrombosis and Stroke

Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry

JACC Heart Fail.

Clerkin KJ, Topkara VK, Demmer RT, Dizon JM, Yuzefpolskaya M, Fried JA, Mai X, Mancini DM, Takeda K, Takayama H, Naka Y, Colombo PC, Garan AR

doi: 10.1016/j.jchf.2017.08.014.

Cardiac Arrest or Death

Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome

J Am Coll Cardiol.

Gonzalez Corcia MC, Sieira J, Pappaert G, de Asmundis C, Chierchia GB, La Meir M, Sarkozy A, Brugada P

doi: 10.1016/j.jacc.2017.10.082.

Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.

JAMA Cardiol.

Marzec LN, Peterson PN, Bao H, Curtis JP, Masoudi FA, Varosy PD, Bradley SM

doi: 10.1001/

Heart, Artery and Coronary Diseases

Survival Following Implantable Cardioverter-Defibrillator Implantation in Patients With Amyloid Cardiomyopathy

J Am Heart Assoc.

Higgins AY, Annapureddy AR, Wang Y, Minges KE, Lampert R, Rosenfeld LE, Jacoby DL, Curtis JP, Miller EJ, Freeman JV

doi: 10.1161/JAHA.120.016038.

Related content